Literature DB >> 28742898

Association of the Priority Review Voucher With Neglected Tropical Disease Drug and Vaccine Development.

Nina Jain1, Thomas Hwang1, Jessica M Franklin1, Aaron S Kesselheim1.   

Abstract

Mesh：

Year:  2017        PMID： 28742898      PMCID： PMC5817607          DOI： 10.1001/jama.2017.7467

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Experience With the Priority Review Voucher Program for Drug Development.

Authors:  Aaron S Kesselheim; Lara R Maggs; Ameet Sarpatwari
Journal:  JAMA       Date:  2015-10-27       Impact factor: 56.272

2.  The Commercial Market For Priority Review Vouchers.

Authors:  David B Ridley; Stephane A Régnier
Journal:  Health Aff (Millwood)       Date:  2016-05-01       Impact factor: 6.301
  2 in total
  6 in total

Review 1.  Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most.

Authors:  Temmy Sunyoto; Julien Potet; Marleen Boelaert
Journal:  BMJ Glob Health       Date:  2018-05-03

2.  Is the priority review voucher program stimulating new drug development for tropical diseases?

Authors:  Kirk W Kerr; Thomas C Henry; Kathleen L Miller
Journal:  PLoS Negl Trop Dis       Date:  2018-08-09

3.  Optimization of 1,4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi.

Authors:  Leonardo S Lara; Guilherme C Lechuga; Caroline Dos S Moreira; Thaís B Santos; Vitor F Ferreira; David R da Rocha; Mirian C S Pereira
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

4.  Antiparasitic Drugs in the United States-Two Roads to High Prices.

Authors:  Arman A Shahriar; Jonathan D Alpern
Journal:  Front Sociol       Date:  2020-10-22

Review 5.  Innovation in neglected tropical disease drug discovery and development.

Authors:  Hong-Bo Weng; Hai-Xia Chen; Ming-Wei Wang
Journal:  Infect Dis Poverty       Date:  2018-06-18       Impact factor: 4.520

6.  Oral treatment with T6-loaded yeast cell wall particles reduces the parasitemia in murine visceral leishmaniasis model.

Authors:  Débora B Scariot; Hélito Volpato; Nilma S Fernandes; Danielle Lazarin-Bidóia; Olga Borges; Maria do Céu Sousa; Fernanda A Rosa; Andrey P Jacomini; Sueli O Silva; Tânia Ueda-Nakamura; Adley F Rubira; Celso V Nakamura
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.